ER-Positive
Showing 26 - 50 of >10,000
Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)
Recruiting
- Estrogen Receptor-positive Breast Cancer
- HER2-positive Breast Cancer
- Palbociclib
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Hospital
Sep 29, 2021
Metastatic Breast Cancer Trial in Changsha (Pyrotinib Maleate plus Letrozole)
Recruiting
- Metastatic Breast Cancer
- Pyrotinib Maleate plus Letrozole
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Oct 12, 2021
ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant
Recruiting
- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Palbociclib 125Mg Tab
- +5 more
-
Christchurch, United Kingdom
- +3 more
May 19, 2022
Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- AND019 PO QD
-
Nashville, TennesseeSarah Cannon Research Institute
Jul 19, 2022
Breast Cancer, HER2-negative Breast Cancer, Node-negative Breast Cancer Trial in Lexington (Anastrozole 1mg, Letrozole 2.5mg,
Recruiting
- Breast Cancer
- +3 more
- Anastrozole 1mg
- +3 more
-
Lexington, KentuckyUniversity of Kentucky Markey Cancer Center
Jan 3, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- Prognostic Stage IV Breast Cancer AJCC v8
- Pembrolizumab
- +2 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 5, 2023
Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)
Recruiting
- Hormone Receptor Positive HER-2 Negative Breast Cancer
- Docetaxel
- +3 more
-
Shanghai, Shanghai, ChinaBreast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023
Breast Tumor, Chemo Effect Trial in Netherlands (trifluridine/tipiracil)
Recruiting
- Breast Neoplasm
- Chemotherapy Effect
-
Arnhem, Netherlands
- +9 more
Mar 3, 2022
Breast Cancer Trial in Shanghai (SCR-6852, Palbociclib)
Recruiting
- Breast Cancer
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
May 18, 2022
ER-Positive, HER2-Negative Breast Cancer Trial in Shanghai (HRS8807, HRS8807?SHR6390)
Recruiting
- ER-Positive, HER2-Negative Breast Cancer
- HRS8807
- HRS8807、SHR6390
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Nov 15, 2021
Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Alpelisib, Tamoxifen, Infigratinib)
Not yet recruiting
- Breast Cancer
- +2 more
- Alpelisib
- +3 more
-
Stanford, CaliforniaStanford University
Nov 16, 2022
Breast Cancer Trial in United States (Neratinib, Fulvestrant)
Active, not recruiting
- Breast Cancer
-
Indianapolis, Indiana
- +5 more
Mar 2, 2022
Immune Environment in Response to Therapy in Breast Cancer
Recruiting
- Breast Cancer
- +3 more
- Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.
-
Philadelphia, PennsylvaniaAbramson Cancer Center
Sep 15, 2022
Breast Cancer Trial in Guangzhou (Everolimus, Letrozole, Fluorouracil)
Completed
- Breast Cancer
- Everolimus
- +4 more
-
Guangzhou, Guangdong, ChinaSun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
Sep 22, 2021
Metastatic Breast Cancer Trial in Chuo-ku, Nihonbashi, Koami-cho (Paclitaxel, Bevacizumab, Letrozole)
Completed
- Metastatic Breast Cancer
- Paclitaxel
- +7 more
-
Chuo-ku, Nihonbashi, Koami-cho, Tokyo, JapanJapan Breast Cancer Research Group
Aug 2, 2022
Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)
Completed
- Estrogen Receptor Positive Breast Cancer
-
Houston, Texas
- +2 more
Aug 27, 2021
Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed
Recruiting
- Triple Negative Breast Cancer
- HER2-negative Breast Cancer
- HER2 - primed Dendritic cells
- HER3 - primed Dendritic cells
-
Tampa, FloridaMoffitt Cancer Center
Jan 10, 2023
Metastatic Breast Cancer Trial in United States (Lenvatinib, Pembrolizuma, Fulvestrant)
Not yet recruiting
- Metastatic Breast Cancer
- Lenvatinib
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Oct 31, 2023
Metastatic Breast Cancer Trial in Johannesburg (Palbociclib, Exemestane, Goserelin)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
-
Johannesburg, South AfricaWits Oncology center
Jul 22, 2021
Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer Trial (palbociclib and exemestane plus trastuzumab and
Not yet recruiting
- Neoadjuvant Treatment for HER2-positive, ER-positive Breast Cancer
- palbociclib and exemestane plus trastuzumab and pyrotinib
- (no location specified)
Apr 23, 2021
Breast Cancer Stage IV Trial in Irvine (Gallium-68)
Recruiting
- Breast Cancer Stage IV
-
Irvine, CaliforniaHoag Memorial Hospital Presbyterian
May 26, 2023